Пятый элемент здоровья. Как использовать менструальный цикл для поддержания жизненно важных функций организма - Лиза Хендриксон-Джек

(1974): 85–88; Shaarawy, M., M. Fayad, A.R. Nagui, and S. Abdel-Azim. “Serotonin metabolism and depression in oral contraceptive users.” Contraception 26, no. 2 (1982): 193–204.

48. Pelton, Ross. “The pill problem: how to protect your health from the side effects of oral contraceptives. Natural Pharmacist, 2013; Owens, Michael J., and Charles B. Nemeroff. “Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.” Clinical Chemistry 40, no. 2 (1994): 288–295.

49. Leeton, John. “Depression induced by oral contraception and the role of vitamin B6 in its management.” Australian and New Zealand Journal of Psychiatry 8, no. 2 (1974): 87; Kishi, H., T. Kishi, R.H. Williams, T. Watanabe, K. Folkers, and M.L. Stahl. “Deficiency of vitamin B6 in women taking contraceptive formulations.” Research Communications in Chemical Pathology and Pharmacology 17, no. 2 (1977): 283–293; Webb, J.L. “Nutritional effects of oral contraceptive use: a review.” The Journal of Reproductive Medicine 25, no. 4 (1980): 150–156; Luhby, A. Leonard, Myron Brin, Myron Gordon, Patricia Davis, Maureen Murphy, and Herbert Spiegel. “Vitamin B6 metabolism in users of oral contraceptive agents. I. Abnormal urinary xanthurenic acid excretion and its correction by pyridoxine.” The American Journal of Clinical Nutrition 24, no. 6 (1971): 684–693; Winston, F. “Oral contraceptives pyridoxine and depression.” American Journal of Psychiatry 130, no. 11 (1973): 1217–1221; Adams, P. W., V. Wynn, D.P. Rose, M. Seed, J. Folkard, and R. Strong. “Effect of pyridoxine hydrochloride (vitamin B6) upon depression associated with oral contraception.” The Lancet 301, no. 7809 (1973): 897–904.

50. Skovlund, Charlotte Wessel, Lina Steinrud Mørch, Lars Vedel Kessing, and Øjvind Lidegaard. “Association of hormonal contraception with depression.” JAMA Psychiatry 73, no. 11 (2016): 1154–1162; Gingnell, Malin, Jonas Engman, Andreas Frick, Lena Moby, Johan Wikström, Mats Fredrikson, and Inger Sundström-Poromaa. “Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill – a double-blinded, placebo– controlled randomized trial of a levonorgestrel-containing combined oral contraceptive.” Psychoneuroendocrinology 38, no. 7 (2013): 1133–1144.

51. Schaffir, Jonathan, Brett L. Worly, and Tamar L. Gur. “Combined hormonal contraception and its effects on mood: a critical review.” The European Journal of Contraception & Reproductive Health Care 21, no. 5 (2016): 347–355.

52. Wiebe, Ellen R., Lori A. Brotto, and Jacqueline MacKay. “Characteristics of women who experience mood and sexual side effects with use of hormonal contraception.” Journal of Obstetrics and Gynaecology Canada 33, no. 12 (2011): 1234–1240.

53. Там же, 1236.

54. Там же, 1234.

55. Там же, 1237.

56. Там же, 1237.

57. Там же, 1239.

58. Behre, Hermann M., Michael Zitzmann, Richard A. Anderson, David J. Handelsman, Silvia W. Lestari, Robert I. McLachlan, M. Cristina Meriggiola et al. “Efficacy and safety of an injectable combination hormonal Contraceptive for men.” The Journal of Clinical Endocrinology & Metabolism 101, no. 12 (2016): 4779–4788.

59. Там же, 4782.

60. Там же, 4781.

61. Там же, 4784.

62. Там же, 4783.

63. Там же, 4781.

64. Там же, 4781.

65. Havlicek, Jan, S. Craig Roberts, and Jaroslav Flegr. “Women’s preference for dominant male odour: effects of menstrual cycle and relationship status.” Biology Letters 1, no. 3 (2005): 256–259; Havlicek, Jan, and S. Craig Roberts. “MHC-correlated mate choice in humans: a review.” Psychoneuroendocrinology 34, no. 4 (2009): 497–512; Wedekind, Claus, and Sandra Füri. “Body odour preferences in men and women: do they aim for specific MHC combinations or simply heterozygosity?” Proceedings of the Royal Society of London B: Biological Sciences 264, no. 1387 (1997): 1473–1478; Thornhill, Randy, Steven W. Gangestad, Robert Miller, Glenn Scheyd, Julie K. McCollough, and Melissa Franklin. “Major histocompatibility complex genes, symmetry, and body scent attractiveness in men and women.” Behavioral Ecology 14, no. 5 (2003): 668–678; Little, Anthony C., Benedict C. Jones, and Robert P. Burriss. “Preferences for masculinity in male bodies change across the menstrual cycle.” Hormones and Behavior 51, no. 5 (2007): 633–639.

66. Havlicek, Jan, and S. Craig Roberts. “MHC-correlated mate choice in humans: a review.” Psychoneuroendocrinology 34, no. 4 (2009): 498; Wedekind, Claus, and Sandra Füri. “Body odour preferences in men and women: do they aim for specific MHC combinations or simply heterozygosity?” Proceedings of the Royal Society of London B: Biological Sciences 264, no. 1387 (1997): 1471; Penn, Dustin J. “The scent of genetic compatibility: sexual selection and the major histocompatibility complex.” Ethology 108, no. 1 (2002): 1–21.

67. Thornhill, Randy, Steven W. Gangestad, Robert Miller, Glenn Scheyd, Julie K. McCollough, and Melissa Franklin. “Major histocompatibility complex genes, symmetry, and body scent attractiveness in men and women.” Behavioral Ecology 14, no. 5 (2003): 668–678.

68. Havlicek, Jan, S. Craig Roberts, and Jaroslav Flegr. “Women’s preference for dominant male odour: effects of menstrual cycle and relationship status.” Biology Letters 1, no. 3 (2005): 256–257; Wedekind, Claus, and Sandra Füri. “Body odour preferences in men and women: do they aim for specific MHC combinations or simply heterozygosity?” Proceedings of the Royal Society of London B: Biological Sciences 264, no. 1387 (1997): 1476–1477; Alvergne, Alexandra, and Virpi Lummaa. “Does the contraceptive pill alter mate choice in humans?” Trends in Ecology & Evolution 25, no. 3 (2010): 171–179; Roberts, S. Craig, Anthony C. Little, L. Morris Gosling, David I. Perrett, Vaughan Carter, Benedict C. Jones, Ian Penton-Voak, and Marion Petrie. “MHC-heterozygosity and human facial attractiveness.” Evolution and Human Behavior 26, no. 3 (2005): 213–226; Penn, Dustin J. “The scent of genetic compatibility: sexual selection and the major histocompatibility complex.” Ethology 108, no. 1 (2002): 5–8; Ober, Carole, Lowell R. Weitkamp, Nancy Cox, Harvey Dytch, Donna Kostyu, and Sherman Elias. “HLA and mate choice in humans.” The American Journal of Human Genetics 61, no. 3 (1997): 497–504.

69. Little, Anthony C., Benedict C. Jones, and Robert P. Burriss. “Preferences for masculinity in male bodies change across the menstrual cycle.” Hormones and Behavior 51, no. 5 (2007): 637; O’Connor, Jillian J.M., David R. Feinberg, Paul J. Fraccaro, Diana J. Borak, Cara C. Tigue, Daniel E. Re, Benedict C. Jones, Anthony C. Little, and Bernard Tiddeman. “Female preferences for male vocal and facial masculinity in videos.” Ethology 118, no. 4 (2012): 321–330; Little, Anthony C., Benedict C. Jones, D. Michael Burt, and David I. Perrett. “Preferences for symmetry in faces change across the menstrual cycle.” Biological Psychology 76, no. 3 (2007): 209–216; Debruine,